Maintenance therapy with a poly(adp-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis☆

HIGHLIGHTS

• who: S. Gulia from the Department of Medical Oncology, Tata Memorial CentreIndia have published the article: Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis☆, in the Journal: (JOURNAL)
• what: As expected, collated trial-level analysis of combined data from four studies showed a significantly higher risk of several hematological and nonhematological toxicities in the PARPi group compared with placebo, which have to be considered in clinical decisions.
• how: The authors conducted and report here an . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.